Relapsed Cancer

28 clinical trials · Condition

Record	Firm	Date
A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451)	Lyell Immunopharma, Inc.	2022-03-29
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma (NCT04510636)	University Health Network, Toronto	2021-12-20
Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents (NCT04310345)	Vanderbilt-Ingram Cancer Center	2021-03-31
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers (NCT04092179)	University Health Network, Toronto	2020-11-05
Pembrolizumab, Ibrutinib and Rituximab in PCNSL (NCT04421560)	Dana-Farber Cancer Institute	2020-08-01
Lorlatinib Combinations in Lung Cancer (NCT04292119)	Massachusetts General Hospital	2020-05-01
Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents (NCT03765099)	Vanderbilt-Ingram Cancer Center	2019-02-21
Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS (NCT03187288)	University Health Network, Toronto	2018-05-25
PRecISion Medicine for Children With Cancer (NCT03336931)	Sydney Children's Hospitals Network	2017-09-05

Every clearance here is in the API, with alerts when new ones post.